Inflammation treatment may help curb obesity, type 2 diabetes

07/10/2013 | American City Business Journals

Researchers at the University of Georgia's College of Pharmacy have successfully tested several anti-inflammatory compounds in mice that prevented weight gain and reduced the incidence of obesity-related conditions that can lead to type 2 diabetes. In one case, scientists injected mice with a plant pigment called rutin found in fruits and vegetables; in another, the mice were injected with interleukin 10. Both treatments controlled weight, reduced inflammation and prevented early signs of liver disease and diabetes.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY